TARSONS.NS
Tarsons Products Limited [TARSONS.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TARSONS.NS Stock Summary
Top 10 Correlated Stocks
TARSONS.NS
In the News
TARSONS.NS Financial details
Company Rating
-
Market Cap
29.44B
Income
699.99M
Revenue
2.77B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
713
Optionable
No
Shortable
Yes
Earnings
14 Aug 2023
P/E
42.23
Forward P/E
-
PEG
-13.02
P/S
10.64
P/B
5.19
P/C
-
P/FCF
-
Quick Ratio
2
Current Ratio
4.01
Debt / Equity
-
LT Debt / Equity
0.14
-
-
EPS (TTM)
13.15
EPS next Y
-
EPS next Q
-
EPS this Y
-22.05%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.67%
Revenue last 5Y
9.78%
Revenue Q/Q
-23.75%
EPS Q/Q
-58.04%
-
-
-
-
SMA20
5.64%
SMA50
-11.56%
SMA100
-1.45%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
13%
ROC
0.15%
Gross Margin
76%
Oper. Margin
36%
Profit Margin
25%
Payout
-
Shs Outstand
53.21M
Shs Float
15.57M
-
-
-
-
Target Price
-
52W Range
501.1-847.95
52W High
-34.56%
52W Low
+10.63%
RSI
59
Rel Volume
0.33
Avg Volume
128.75K
Volume
42.19K
Perf Week
3.1%
Perf Month
-0.9%
Perf Quarter
-2.21%
Perf Half Y
3.96%
-
-
-
-
Beta
-
-
-
Volatility
11.9%, 13.63%
Prev Close
-1.26%
Price
554.25
Change
0.83%
TARSONS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 34.88 | 34.3 | 44.74 | 57.83 | 53.24 | |
| Net income per share | 7.65 | 7.94 | 13.52 | 19.46 | 15.17 | |
| Operating cash flow per share | 10.08 | 12.59 | 13.38 | 16.13 | 14.21 | |
| Free cash flow per share | 3.42 | 7.49 | 0.75 | -9.37 | -21.5 | |
| Cash per share | 0.1 | 4.96 | 0.46 | 16.6 | 11.28 | |
| Book value per share | 26.56 | 38.72 | 47.97 | 94.67 | 107 | |
| Tangible book value per share | 26.56 | 38.72 | 47.85 | 94.54 | 106.9 | |
| Share holders equity per share | 26.56 | 38.72 | 47.97 | 94.67 | 107 | |
| Interest debt per share | 14.08 | 8.17 | 7.11 | 4.96 | 21.64 | |
| Market cap | 41.69B | 41.75B | 41.69B | 36.37B | 28.31B | |
| Enterprise value | 42.33B | 41.86B | 42B | 35.81B | 28.83B | |
| P/E ratio | 107.01 | 103.02 | 60.53 | 36.13 | 35.08 | |
| Price to sales ratio | 23.46 | 23.86 | 18.29 | 12.16 | 10 | |
| POCF ratio | 81.2 | 65.02 | 61.17 | 43.57 | 37.45 | |
| PFCF ratio | 239.54 | 109.26 | 1.09K | -74.99 | -24.76 | |
| P/B Ratio | 30.82 | 21.13 | 17.06 | 7.43 | 4.97 | |
| PTB ratio | 30.82 | 21.13 | 17.06 | 7.43 | 4.97 | |
| EV to sales | 23.82 | 23.92 | 18.43 | 11.97 | 10.18 | |
| Enterprise value over EBITDA | 54.74 | 57.3 | 38.63 | 22.26 | 20.35 | |
| EV to operating cash flow | 82.45 | 65.19 | 61.63 | 42.91 | 38.14 | |
| EV to free cash flow | 243.22 | 109.54 | 1.1K | -73.84 | -25.21 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | |
| Free cash flow yield | 0 | 0.01 | 0 | -0.01 | -0.04 | |
| Debt to equity | 0.48 | 0.18 | 0.14 | 0.04 | 0.19 | |
| Debt to assets | 0.3 | 0.14 | 0.11 | 0.04 | 0.15 | |
| Net debt to EBITDA | 0.83 | 0.15 | 0.29 | -0.35 | 0.36 | |
| Current ratio | 1.8 | 2.96 | 2.7 | 7 | 4.01 | |
| Interest coverage | 8.54 | 10.2 | 34.93 | 34.95 | 25.34 | |
| Income quality | 0.92 | 1.21 | 0.74 | 0.62 | 0.7 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.66 | -0.4 | -0.94 | -1.58 | -2.51 | |
| Capex to revenue | -0.19 | -0.15 | -0.28 | -0.44 | -0.67 | |
| Capex to depreciation | -2.33 | -1.83 | -4.71 | -6.01 | -6.66 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 67.6 | 83.2 | 120.79 | 203.58 | 191.11 | |
| ROIC | 0.21 | 0.19 | 0.25 | 0.2 | 0.12 | |
| Return on tangible assets | 0.18 | 0.16 | 0.23 | 0.19 | 0.11 | |
| Graham Net | -3.01 | 6.45 | -5.09 | 24.72 | 1.91 | |
| Working capital | 430.85M | 794.06M | 710.03M | 2.1B | 1.89B | |
| Tangible asset value | 1.35B | 1.98B | 2.44B | 4.89B | 5.69B | |
| Net current asset value | 204.29M | 687.09M | 611.9M | 1.9B | 956.53M | |
| Invested capital | 0.48 | 0.18 | 0.14 | 0.04 | 0.19 | |
| Average receivables | 0 | 479.84M | 229.03M | 368.07M | 697M | |
| Average payables | 0 | 39.62M | 59.4M | 94.64M | 113M | |
| Average inventory | 0 | 475.88M | 477.13M | 645.36M | 983.74M | |
| Days sales outstanding | 103.04 | 95.55 | 0 | 89.8 | 84.77 | |
| Days payables outstanding | 11.8 | 36.81 | 29.36 | 59.05 | 54.13 | |
| Days of inventory on hand | 271.53 | 303.73 | 229.46 | 375.53 | 641.72 | |
| Receivables turnover | 3.54 | 3.82 | 0 | 4.06 | 4.31 | |
| Payables turnover | 30.92 | 9.92 | 12.43 | 6.18 | 6.74 | |
| Inventory turnover | 1.34 | 1.2 | 1.59 | 0.97 | 0.57 | |
| ROE | 0.29 | 0.21 | 0.28 | 0.21 | 0.14 | |
| Capex per share | -6.66 | -5.1 | -12.63 | -25.51 | -35.7 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 12.91 | 13.38 | 11.53 | 15.42 | 11.74 | |
| Net income per share | 3.82 | 4.03 | 3.03 | 4.29 | 1.8 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 11.81 | 0 | 11.28 | 0 | |
| Book value per share | 0 | 99.85 | 0 | 107 | 0 | |
| Tangible book value per share | 0 | 99.85 | 0 | 106.9 | 0 | |
| Share holders equity per share | 0 | 99.85 | 0 | 107 | 0 | |
| Interest debt per share | 0 | 11.71 | 0 | 21.19 | 0 | |
| Market cap | 38.03B | 43.43B | 36.94B | 28.31B | 32.11B | |
| Enterprise value | 0 | 43.42B | 0 | 28.83B | 0 | |
| P/E ratio | 46.81 | 50.59 | 57.3 | 31.01 | 83.65 | |
| Price to sales ratio | 55.41 | 60.96 | 60.24 | 34.51 | 51.32 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 8.17 | 0 | 4.97 | 0 | |
| PTB ratio | 0 | 8.17 | 0 | 4.97 | 0 | |
| EV to sales | 0 | 60.95 | 0 | 35.14 | 0 | |
| Enterprise value over EBITDA | 0 | 119.27 | 0 | 69.59 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.01 | 0 | 0 | 0.01 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.12 | 0 | 0.19 | 0 | |
| Debt to assets | 0 | 0.1 | 0 | 0.15 | 0 | |
| Net debt to EBITDA | 0 | -0.03 | 0 | 1.25 | 0 | |
| Current ratio | 0 | 3.11 | 0 | 4.01 | 0 | |
| Interest coverage | 64.11 | 40.16 | 18.51 | 16.04 | 6.34 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 95.15 | 0 | 101.62 | 0 | |
| ROIC | 0 | 0.04 | 0 | 0.04 | 0 | |
| Return on tangible assets | 0 | 0.03 | 0 | 0.03 | 0 | |
| Graham Net | 0 | 11.09 | 0 | 1.91 | 0 | |
| Working capital | 0 | 1.58B | 0 | 1.89B | 0 | |
| Tangible asset value | 0 | 5.31B | 0 | 5.69B | 0 | |
| Net current asset value | 0 | 1.37B | 0 | 956.53M | 0 | |
| Invested capital | 0 | 0.12 | 0 | 0.19 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 73.14 | 0 | 72.16 | 0 | |
| Days payables outstanding | 0 | 50.4 | 0 | 42.69 | 0 | |
| Days of inventory on hand | 0 | 538.2 | 0 | 506.1 | 0 | |
| Receivables turnover | 0 | 1.23 | 0 | 1.25 | 0 | |
| Payables turnover | 0 | 1.79 | 0 | 2.11 | 0 | |
| Inventory turnover | 0 | 0.17 | 0 | 0.18 | 0 | |
| ROE | 0 | 0.04 | 0 | 0.04 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
TARSONS.NS Frequently Asked Questions
What is Tarsons Products Limited stock symbol ?
Tarsons Products Limited is a IN stock and trading under the symbol TARSONS.NS
What is Tarsons Products Limited stock quote today ?
Tarsons Products Limited stock price is $554.25 today.
Is Tarsons Products Limited stock public?
Yes, Tarsons Products Limited is a publicly traded company.
Company Profile
- Volume Average 128.75K
- Market Capitalization 29.44B
- Employee 713
- CEO Mr. Sanjive Sehgal
- Headquarters Kolkata,IN
- IPO Date 2021-11-26
-
Website
https://www.tarsons.com 
Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, and safety products and instruments; and bottles, carboys, measuring cylinder, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, breakers, test tube racks, pipette tips, petri dish, centrifuge tubes, cryogenic and storage vials, pasteur pipettes, vortex, and other products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. The company was incorporated in 1983 and is headquartered in Kolkata, India.
